BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.58
-2.33%
Mkt Cap $2.23B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
Implied Upside
+133.2%
Consensus $20.00 vs current $8.58
NASDAQ·Healthcare·Biotechnology
$8.58
-2.33%
Mkt Cap $2.23B
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$20.00
Range $14.00 – $29.00
+133.2%
Consensus $20.00 vs current $8.58